中文名稱：索馬魯肽ELISA試劑盒
英文名稱：Semaglutide ELISA KIT
索馬魯肽ELISA試劑盒相關(guān)產(chǎn)品：
Anti-Semaglutide ELISA Kit (AP899018)
Semaglutide ELISA Kit (DP899018)
鏈接：https://www.abinscience.com/index/search?wd=semaglutide+elisa
介紹：索馬魯肽是新一代GLP-1（胰高血糖素樣肽-1）類似物。索馬魯肽，英文名稱 “Semaglutide”，是一種新型的，長效的，GLP-1類似物，是基于利拉魯肽基本結(jié)構(gòu)而開發(fā)的長效劑型。abinscience產(chǎn)品具有親和力高，靈敏度高，特異性好，穩(wěn)定性強(qiáng)等優(yōu)勢(shì)。
別名：索馬魯肽，CAS, 910463-68-2, Semaglutide, Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217?
貨號(hào)：AP899018，DP899018
靈敏度：6.49 ng/mL
范圍：15.63 - 10,000 ng/mL
應(yīng)用：ELISA
CAS：910463-68-2
生物活性：Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment.
儲(chǔ)存：2-8 ℃
產(chǎn)品購買聯(lián)系方式：027-87433958/18162686757
郵箱：info@abinscience.com
參考文獻(xiàn)：
[1]. Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844. [Content Brief]
[2]. Zhang L, et al. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model. Neuropeptides. 2018 Oct;71:70-80. [Content Brief]
[3]. Dhillon S, et al. Semaglutide: First Global Approval. Drugs. 2018 Feb;78(2):275-284. [Content Brief]